Deca-Durabolin Drug Interactions
Currently displaying a list of 85 drugs known to interact with Deca-Durabolin (nandrolone).
- 11 major drug interactions
- 74 moderate drug interactions
Medications known to interact with Deca-Durabolin
Note: Showing generic names only.
A
B
C
- C1 esterase inhibitor (human)
- calaspargase pegol
- calcipotriene topical
- calcitriol topical
- cannabidiol
- carfilzomib
- chlorpropamide
- clofarabine
- conestat alfa
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
D
E
F
G
H
I
- idelalisib
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isoniazid
K
L
- leflunomide
- levoketoconazole
- levothyroxine
- levothyroxine / liothyronine
- liothyronine
- liotrix
- lomitapide
M
N
P
R
T
- teriflunomide
- thioguanine
- thyroid desiccated
- tolazamide
- tolbutamide
- trabectedin
- triamcinolone
- triamcinolone ophthalmic
V
W
Deca-Durabolin alcohol/food interactions
There is 1 alcohol/food interaction with Deca-Durabolin (nandrolone).
Deca-Durabolin disease interactions
There are 10 disease interactions with Deca-Durabolin (nandrolone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- diabetes
- hypercalcemia
- thyroid function tests
Report options
QR code containing a link to this page
More about Deca-Durabolin (nandrolone)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: androgens and anabolic steroids
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
